Acta Veterinaria et Zootechnica Sinica ›› 2024, Vol. 55 ›› Issue (10): 4278-4289.doi: 10.11843/j.issn.0366-6964.2024.10.004

• Review • Previous Articles     Next Articles

Research Progress on in vitro Culture and Induced Differentiation of Non-human Primate Pluripotent Stem Cells

Kecheng SHEN1(), Jiaqiao ZHU1,2,*(), Zongping LIU1,2   

  1. 1. College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China
    2. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China
  • Received:2023-12-05 Online:2024-10-23 Published:2024-11-04
  • Contact: Jiaqiao ZHU E-mail:kcshen1999@163.com;jqzhu1998@163.com

Abstract:

Stem cells have great value in disease occurrence, cell therapy, drug screening, and clinical applications. Since Shinya Yamanaka, a Japanese scientist, discovered induced pluripotent stem cells (iPSCs), the relevant research has become a research hotspot and up to the present. The study of mouse stem cells has opened up a path for the related research in other animals, but there are significant limitations in drug screening and disease treatment. Non-human primates have higher genetic homology with humans and are highly similar to humans in physiology, pathology, reproduction, pharmacology, nerves, and other aspects. They are ideal animal models for studying human diseases and developing drugs for human. Research on non-human primates is also a necessary step for a new drugs before entering clinical trials. The study of non-human primate stem cells is becoming important in the mechanism of diseases and drug development, while avoiding ethical issues. This article reviews the related research on non-human primate pluripotent stem cells including optimization of in vitro culture systems and methods of inducing differentiation, aiming to provide reference for further in-depth research on non-human primate stem cells.

Key words: non-human primate, pluripotent stem cells, in vitro culture, induced differentiation

CLC Number: